Edwards Lifesciences CVP, TAVR Daniel J. Lippis sells 619 shares for $53,017.35
EW•Daniel J. Lippis sold 619 Edwards Lifesciences shares for $53,017.35 on Oct. 8, 2026, after exercising 619 employee stock options at $72.68; he held 40,033 shares directly afterward.
1. Share transactions
Edwards Lifesciences CVP, TAVR Daniel J. Lippis sold 619 common shares on Oct. 8, 2026, at $85.65 per share, for $53,017.35. The sale followed his exercise of 619 employee stock options at $72.68 per share on the same day. His directly held common shares totaled 40,033 after the transactions.
Related News
First Trust announces adjournment of special shareholder meeting for First Trust Active Global Quality Income ETF
AGQI•
Synopsys reportedly looks to work with Chinese AI labs to speed up chip design
SNPS•
